CHRISTINE BOHLEN: Open Payments
NPI 1801293220 · MADISON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,257 in 72 payments from 23 companies in 2025. Trend: 2023 $358 · 2024 $390 · 2025 $1,257
Food & beverage: $1,257
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $174 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $156 |
| ABBVIE INC. | 16 | $146 |
| Axsome Therapeutics, Inc. | 6 | $110 |
| AstraZeneca Pharmaceuticals LP | 6 | $104 |
| Lundbeck LLC | 3 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Dexcom, Inc. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
Products named: CAPLYTA, VRAYLAR, REXULTI, Wegovy, Sunosi, Kerendia, AIRSUPRA, Ozempic.
Industry payments across GA — which companies pay providers there.
